Welcome to the Investor Centre

Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

We are here for two reasons. One is to make a difference to patients’ lives. Second is to generate a return for our investors.

Latest Annual Report

Annual Report and Accounts

For the year ended 31st Dec 2019

Highlights

£202m

Net Asset Value (at 31 Dec 2019)

149p

NAV per share (at 31 Dec 2019)

26

Clinical trials across the portfolio

£198m

Gross Portfolio Value (at 31 May 2020)

LON:ARIX

Stay up to date

Subscribe to our mailing list to get the latest regulatory news, share price information and results from Arix